Characterisation of neuropeptide Y receptor subtypes by synthetic NPY analogues and by anti-receptor antibodies

Molecules

Volumn 6, Issue 5, 2001, Pages 448-467

  Eckard, Christophe P ^a   Cabrele, Chiara ^a   Wieland, Heike A ^b   Beck Sickinger, Annette G ^a,c  

^a ETH ZURICH   (Switzerland)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Anti receptor antibodies; Ligand binding site; Neuropeptide Y; NPY analogues; NPY receptor; Subtype selectivity

Indexed keywords

G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; RECEPTOR ANTIBODY; RECEPTOR SUBTYPE; RHODOPSIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LIGAND BINDING; NEUROMODULATION; NEWBORN; NONHUMAN; PROTEIN SYNTHESIS; RECEPTOR AFFINITY;

EID: 0000448922     PISSN: 14203049     EISSN: None     Source Type: Journal    
DOI: 10.3390/60500448     Document Type: Conference Paper

References (46)

1. Tatemoto, K.; Carlquist, M.; Mutt, V. Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature, 1982, 296, 659-660.
2. Inui, A. Neuropeptide Y feeding receptors: are multiple subtypes involved? Trends Pharm. Sci., 1999, 20, 43-46.
3. Kalra, S. P.; Crowley, W. R. Neuropeptide Y: a novel neuroendocrine peptide in the control of pituitary hormone secretion, and its relation to luteinizing hormone. Front. Neuroendocrinol., 1992, 13, 1-46.
4. McDonald, J. K.; Lumpkin, M. D.; Samson, W. K.; McCann, S. M. Neuropeptide Y affects secretion of luteinizing hormone and growth hormone in ovariectomized rats. Proc. Natl. Acad. Sci. U.S.A., 1985, 82, 561-564.
5. Moltz, J. H.; McDonald, J. K. Neuropeptide Y: direct and indirect action on insulin secretion in the rat. Peptides, 1985, 6, 1155-1159.
6. Wahlestedt, C.; Yanaihara, N.; Håkanson, R. Evidence for different pre- and postjunctional receptors for neuropeptide Y and related peptides. Regul. Pept., 1986, 13, 307-318.
7. Flood, J. F.; Hernandez, E. N.; Morley, J. E. Modulation of memory processing by neuropeptide Y. Brain Res., 1987, 421, 280-290.
8. Jolicoeur, F. B.; Michaud, J. N.; Rivest, R., Menard, D.; Gaudin, D.; Fournier, A.; St-Pierre, S. Neurobehavioral profile of neuropeptide Y. Brain. Res. Bull., 1991, 26, 265-268.
9. Jolicoeur, F. B.; Michaud, J. N.; Menard, D.; Fournier, A. In vivo structure activity study supports the existence of heterogeneous neuropeptide Y receptors. Brain. Res. Bull., 1991, 26, 309-311.
10. Esteban, J.; Chover, A. J.; Sanchez, P. A.; Mico, J. A.; Gibert-Rahola, J. Central administration of neuropeptide Y induces hypothermia in mice. Possible interaction with central noradrenergic systems. Life Sci., 1989, 45, 2395-2400.
11. Clark, J. T.; Kalra, P. S.; Kalra, S. P. Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. Obes. Res., 1997, 5, 275-283.
12. Calza, L.; Giardino, L.; Zanni, M.; Velardo, A.; Parchi, P.; Marrama, P. Daily changes of neuropeptide Y-like immunoreactivity in the suprachiasmatic nucleus of the rat. Regul. Pept., 1990, 27, 127-137.
13. McAuley, M. A.; Chen, X.; Westfall, T. C. Central cardiovascular actions of neuropeptide Y. In: The biology of neuropeptide Y and related peptides; Colmers, W. F., Wahlestedt, C. (ed.), Humana Press Inc., Totowa. 1993; pp. 389-418.
14. Heilig, M. Neuropeptide Y in relation to behavior and psychiatric disorders: some animal and clinical observations. In: The biology of neuropeptide Y and related peptides; Colmers, W. F., Wahlestedt, C. (ed.), Humana Press Inc., Totowa. 1993; pp. 511-555.
15. Thiele, T. E.; Marsh, D. J.; Marie, L. S., Bernstein, I. L.; Palmiter, R. D. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature, 1998, 396, 366-369.
16. Michel, M. C.; Beck-Sickinger, A. G.; Cox, H.; Doods, H. N.; Herzog, H.; Larhammar, D.; Quirion, R.; Schwartz, T.; Westfall, T. XVI. International union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev., 1998, 50, 143-150.
17. Krause, J.; Eva, C.; Seeburg; P. H.; Sprengel, R. Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor. Mol. Pharmacol., 1992, 41, 817-821.
18. Larhammar, D.; Blomqvist, A. G.; Yee, F.; Jazin, E.; Yoo, H.; Wahlestedt, C. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J. Biol. Chem., 1992, 267, 10935-10938.
19. Herzog, H.; Hort, Y. J.; Ball, H. J.; Hayes, G.; Shine, J.; Selbie, L. A. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc. Natl. Acad. Sci. U.S.A., 1992, 89, 5794-5798.
20. Rose, P. M.; Fernandes, P.; Lynch, J. S.; Frazier, S. T.; Fisher, S. M.; Kodukula, K.; Kienzle, B.; Seethala, R. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J. Biol. Chem., 1995, 270, 29038.
21. Gerald, C.; Walker, M. W.; Vaysse, P. J.; He, C.; Branchek, T. A.; Weinshank, R. L. Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype. J. Biol. Chem., 1995, 270, 26758-26761.
22. Gehlert, D. R.; Beavers, L. S.; Johnson, D., Gackenheimer; S. L., Schober, D. A.; Gadski, R. A. Expression cloning of a human brain neuropeptide Y Y2 receptor. Mol. Pharmacol., 1996, 49, 224-228.
23. Lundell, I.; Blomqvist, A. G.; Berglund, M. M.; Schober, D. A.; Johnson, D.; Statnick, M. A.; Gadski, R. A.; Gehlert, D. R.; Larhammar, D. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J. Biol. Chem., 1995, 270, 29123-29128.
24. Bard, J. A.; Walker, M. W.; Branchek, T. A.; Weinshank, R. L. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J. Biol. Chem., 1995, 270, 26762-26765.
25. Gerald, C.; Walker, M. W.; Criscione, L.; Gustafson, E. L.; Batzl-Hartmann, C.; Smith, K. E.; Vaysse, P.; Durkin, M. M.; Laz, T. M.; Linemeyer, D. L.; Schaffhauser, A. O.; Whitebread, S.; Hofbauer, K. G.; Taber, R. I., Branchek; T. A.; Weinshank, R. L. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature, 1996, 382, 168-171.
26. Weinberg, D. H.; Sirinathsinghji, D. J.; Tan, C. P.; Shiao, L. L.; Morin, N.; Rigby, M. R.; Heavens, R. H.; Rapoport, D. R.; Bayne, M. L.; Cascieri, M. A.; Strader, C. D.; Linemeyer, D. L.; MacNeil, D. J. Cloning and expression of a novel neuropeptide Y receptor. J. Biol. Chem., 1996, 271, 16435-16438.
27. Beck-Sickinger, A. G. Structural characterization and binding sites of G-protein coupled receptors. Drug Discov. Today, 1996, 1, 502-513.
28. Ingenhoven, N.; Beck-Sickinger, A. G. Fluorescent labelled analogues of neuropeptide Y for the characterization of cells expressing NPY receptor subtypes. J. Rec. & Signal Transd. Res., 1997, 17, 407-418.
29. Beck-Sickinger, A. G.; Jung, G. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors. Biopolymers, 1995, 37, 123-142.
30. Rist, B.; Wieland, H. A.; Willim, K. D.; Beck-Sickinger, A. G. A rational approach for the development of reduced-size analogues of neuropeptide Y with high affinity to the Y1 receptor. J. Pept. Sci., 1995, 1, 341-348.
31. Jahns, R.; Siegmund, C.; Jahns, V.; Reilander, H.; Maidhof, A.; Muller-Esterl, W.; Lohse, M. J.; Boege, F. Probing human beta 1- and beta 2-adrenoceptors with domain-specific fusion protein antibodies. Eur. J. Pharm., 1996, 316, 111-121.
32. Wall, S. J.; Yasuda, R. P.; Hory, F.; Flagg, S.; Martin, B. M.; Ginns, E. I.; Wolfe, B. B. Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain. Mol. Pharmacol., 1991, 39, 643-649.
33. Muller-Newen, G.; Kohne, C.; Keul, R.; Hemmann, U.; Muller-Esterl, W.; Wijdenes, J.; Brakenhoff, J. P.; Hart, M. H.; Heinrich, P. C. Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing. Eur. J. Biochem., 1996, 236, 837-842.
34. Abd Alla, S.; Godovac-Zimmermann, J.; Braun, A.; Roscher, A. A.; Muller-Esterl, W.; Quitterer, U. Structure of the bradykinin B2 receptors' amino terminus. Biochemistry, 1996, 35, 7514-7519.
35. Van den Pol, A. N.; Romano, C.; Ghosh, P. Metabotropic glutamate receptor mGluR5 subcellular distribution and developmental expression in hypothalamus. J. Comp. Neurol., 1995, 362, 134-150.
36. Westphal, R. S.; Backstrom, J. R.; Sanders-Bush, E. Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization. Mol. Pharmacol., 1995, 48, 200-205.
37. Palmer, T. M.; Gettys, T. W.; Jacobson, K. A.; Stiles, G. L. Desensitization of the canine A2a adenosine receptor: delineation of multiple processes. Mol. Pharmacol., 1994, 45, 1082-1094.
38. Ingenhoven, N.; Eckard, C. P.; Gehlert, D. R.; Beck-Sickinger, A. G. Molecular characterization of the human neuropeptide Y Y2-receptor. Biochemistry, 1999, 38, 6897-6902.
39. Rist, B.; Ingenhoven, N.; Scapozza, L.; Schnorrenberg, G.; Gaida, W.; Wieland, H. A.; Beck-Sickinger, A. G. The bioactive conformation of neuropeptide Y analogues at the human Y2-receptor. Eur. J. Biochem., 1997, 247, 1019-1028.
40. Beck-Sickinger, A. G.; Wieland, H. A.; Wittneben, H.; Willim, K. D.; Rudolf, K.; Jung, G. Complete L-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations. Eur. J. Biochem., 1994, 225, 947-958.
41. Allen, J.; Novotny, J.; Martin, J.; Heinrich, G. Molecular structure of mammalian neuropeptide Y: analysis by molecular cloning and computer-aided comparison with crystal structure of avian homologue. Proc. Nat. Acad. Sci. U.S. A., 1987, 84, 2532-2536.
42. Beck, A. G.; Jung, G.; Gaida, W.; Köppen, H.; Lang, R.; Schnorrenberg, G. Highly potent and small neuropeptide Y agonist obtained by linking NPY 1-4 via spacer to a-helical NPY 25-36. FEBS Lett., 1989, 244, 119-122.
43. Rist, B.; Entzeroth, M.; Beck-Sickinger, A. G. From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor. J. Med. Chem., 1998, 41, 117-123.
44. Wieland, H. A.; Eckard, C. P.; Doods, H. N.; Beck-Sickinger, A. G. Probing of the neuropeptide Y-Y-1-receptors interaction with anti-receptor antibodies. Eur. J. Biochem., 1998, 255, 595-603.
45. Eckard, C. P.; Beck-Sickinger, A. G. Anti-receptor antibodies to characterize G-protein coupled receptors, Curr. Med. Chem., 2000, 7, 897-910.
46. Jacques, D.; Tong, Y.; Dumont, Y.; Shen, S. H.; Quirion, R. Expression of the neuropeptide Y Y1 receptor mRNA in the human brain: an in situ hybridization study. Neuroreport, 1996, 7, 1053-1056.